Prostate cancer
News/ News/ Oncology/ Top stories
AZ/Merck & Co take on Clovis as FDA approves prostate cancer drug
Richard Staines
AstraZeneca, cancer, Clovis, Merck & Co, Oncology, Prostate cancer
0 Comment
Clovis steals march on AZ with PARP prostate approval
Richard Staines
AstraZeneca, cancer, Clovis, Prostate cancer, Rubraca
0 Comment
Xtandi takes fight to prostate cancer rivals with survival data
Phil Taylor
Astellas, Oncology, Pfizer, Prostate cancer, Xtandi
0 Comment
AZ and MSD’s Lynparza gets fast prostate cancer FDA review
Richard Staines
AstraZeneca, cancer, Clovis, Prostate cancer
0 Comment
AZ sells ex-US rights to old cancer drugs Arimidex and Casodex
Richard Staines
AstraZeneca, breast cancer, cancer, Prostate cancer
0 Comment
Xtandi catches up with Erleada in castration-sensitive prostate cancer
Phil Taylor
Astellas, Erleada, Oncology, Pfizer, Prostate cancer, Xtandi
0 Comment
Merck & Co’s Keytruda shows promise with prostate cancer ‘super responders’
Richard Staines
cancer, Merck & Co, Prostate cancer
0 Comment